Mitesco (MITI) Asset Writedowns and Impairment (2017 - 2025)

Mitesco (MITI) posted quarterly Asset Writedowns and Impairment of $86670.0 for Q4 2025, up 1142.4% quarter-over-quarter from $6976.0 in Q3 2025.

Mitesco (MITI) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends

Mitesco (MITI) has reported Asset Writedowns and Impairment for 4 consecutive years, with $86670.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $86670.0; the TTM figure through Mar 2026 stood at $103334.0 (up 966.73% YoY), while the FY2025 annual figure was $113021.0, changed N/A from the prior year.
Asset Writedowns and Impairment rose to $86670.0 in Q4 2025 per MITI's latest filing, from $6976.0 in the prior quarter.
Across five years, Asset Writedowns and Impairment topped out at $1.1 million in Q1 2023 and bottomed at -$970778.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	Mitesco	533,866.19	532,333.19	-

Download Data